Columbia Care Launches First of Its Kind Medical Cannabis Capsule in UK; Provides More Precise Dosing Option and Longer Lasting Therapeutic Benefits for Physicians and Patients

2y
4m read
Summary

For more information on the UK medical cannabis program, visit The Centre for Medicinal Cannabis at https://thecmcuk.org/. These dosing options enable prescribing physicians to offer proven, cannabis-based medical solutions with a degree of precision previously unavailable in the UK market. Prior to the launch of Columbia Care’s solid-fill cannabis powder capsules, UK patients’ and physicians’ formulation options for CBMPs had been limited to cannabis flower and sublingual tinctures made with cannabis extracts. As the UK’s medical cannabis market continues to grow, this formulation has been introduced in response to physician and patient demand for more precise dosing options as well as more familiar form factors in CBMPs. For more information on Columbia Care, please visit www.col-care.com.

Article Preview

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today the launch of its proprietary solid-fill cannabis powder capsule for medicinal use throughout the United Kingdom. This is the first solid-fill capsule of its kind available in the UK and the first dose-metered medicinal cannabis product to be manufactured in the UK. The capsules are part of Columbia Care’s trademarked Ceed medicinal product range.

“Our solid-fill capsule provides numerous advantages for the patient. We believe this has...

Read the full article @ Cannabis Law Report